1.4.1.27: glycine cleavage system
This is an abbreviated version!
For detailed information about glycine cleavage system, go to the full flat file.
Word Map on EC 1.4.1.27
-
1.4.1.27
-
hyperglycinemia
-
nonketotic
-
h-protein
-
lipoic
-
lipoylation
-
one-carbon
-
encephalopathy
-
hydroxymethyltransferase
-
lipoate
-
dihydrolipoamide
-
alpha-keto
-
octanoylation
-
2-oxoacids
-
aminomethyltransferase
-
5,10-methylenetetrahydrofolate
-
dextromethorphan
-
lipoyltransferase
-
aminomethyl
-
alpha-ketoacids
-
1-carbon
-
flaveria
-
dimethylglycine
-
medicine
-
synthesis
- 1.4.1.27
- hyperglycinemia
-
nonketotic
- h-protein
-
lipoic
-
lipoylation
-
one-carbon
- encephalopathy
- hydroxymethyltransferase
- lipoate
- dihydrolipoamide
-
alpha-keto
-
octanoylation
- 2-oxoacids
- aminomethyltransferase
- 5,10-methylenetetrahydrofolate
- dextromethorphan
- lipoyltransferase
-
aminomethyl
- alpha-ketoacids
-
1-carbon
- flaveria
- dimethylglycine
- medicine
- synthesis
Reaction
Synonyms
Amt, At1g11860, At1g32470, At1g48030, AT2G35370, At4g33010, DLD, DLDH, GCSH, GCV, GcvH, GcvP, GCVT, GDCSH, GDCSP, GDH1, GDSCT, GLDC, glycine cleavage complex, H-protein, LpdA, P-protein, sll0171, slr1096, T-protein
ECTree
Advanced search results
Engineering
Engineering on EC 1.4.1.27 - glycine cleavage system
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
additional information
identification of mutations c.664C4T, c.688G4C, c.794G4A, c.826G4C and one heterozygous deletion causing frameshift mutation (c.982delG) in the AMT gene, mutations c.673T4C, c.883G4T, c.1114C4T, c.1525C4G, c.1607G4A, c.1789G4A and c.2280C4G in the GldC gene of patients with clinical and biochemical features suggestive of glycine encephalopathy
additional information
-
identification of mutations c.664C4T, c.688G4C, c.794G4A, c.826G4C and one heterozygous deletion causing frameshift mutation (c.982delG) in the AMT gene, mutations c.673T4C, c.883G4T, c.1114C4T, c.1525C4G, c.1607G4A, c.1789G4A and c.2280C4G in the GldC gene of patients with clinical and biochemical features suggestive of glycine encephalopathy